Discover and read the best of Twitter Threads about #StridesPharma
Most recents (3)
#StridesPharma Sciences Q3 FY22 concall highlights 💊💊
1. Revenues for the quarter stood at ₹796 Cr (5% decline YoY).
2. Gross margins decline by 840 bps YoY.
1. Revenues for the quarter stood at ₹796 Cr (5% decline YoY).
2. Gross margins decline by 840 bps YoY.
3. Gross margin compression is due to product mix and they had inventory of increased RM prices which were adjusted to the lower realizations they received.
4. They are seeing an uptick in opportunities in the regulated markets and are expecting to see a sequential recovery from here. They believe that some of the products that they let go due to increased competition is playing in their favor.
Now that results are out, lets understand what happened with #StridesPharma and where do we go from here 🧵👇🏼
Strides today reported a 24% YoY / 12% QoQ decline in revenue and reduction in Gross Margins to 49.5% (first time ever in last 12 quarters)
The company also reported a first ever Op. Loss in its entire history.
The company also reported a first ever Op. Loss in its entire history.
The only market that did perform was Africa, which reported a 4% QoQ growth. Everything else was a washout.
1 new chart everyday, it could be from any space ~ equities / commodities / crypto / forex / bonds , etc
Will try to do it daily 🙏💪
Here's the first one 👇
SBI vs BankNifty
Ratio chart has given monthly breakout implying SBI could outperform BN in coming months.
#PB365
Will try to do it daily 🙏💪
Here's the first one 👇
SBI vs BankNifty
Ratio chart has given monthly breakout implying SBI could outperform BN in coming months.
#PB365
